Published: June 18, 2026
The Digital Pathology Market was valued at USD 1.12 billion in 2025 and is estimated to grow to USD 1.34 billion in 2026. Supported by the increasing adoption of whole slide imaging, growing integration of artificial intelligence into diagnostic workflows, and the expansion of telepathology infrastructure in emerging markets, the industry is projected to reach USD 6.84 billion by 2035, registering a CAGR of 19.8% during the forecast period from 2026 to 2035., according to a new research report by Next Move Strategy Consulting.
Digital pathology, also known as digital imaging, is a computer enabled technology that allows management of imaging information generated through digital slides. Increased growth of the digital pathology market is fuelled by factors like ease of operation, cost effective scanners and growing popularity. Also, digital imaging has numerous advantages over conventional ways of scanning such as high-resolution imaging and online storage of sample slides. However, lack of reimbursement policies coupled with high costs and unwillingness of older pathologists to switch to newer diagnostic tools are factors expected to restrict the market growth during the forecast period.
Based on product, the digital pathology market share is segmented into scanner, software & storage and communication system. Based on application, the market is segmented into teleconsultation, disease diagnosis, drug discovery and training and education. Based on end user, the market has been segmented into educational, clinical and pharma and biotech companies. Based on geographical analysis, the market is segmented into North America, Europe, Asia Pacific and RoW.
At present, due to higher adoption of digital pathology along with presence of major market players, the North America region possesses the lion share in the digital pathology market. However, Asia Pacific is expected to show exponential growth within the forecast period owing to the factors such as improved health care infrastructure and increasing adoption of advanced imaging modalities in this region.
According to the report, some the key players in the market are PathAI Inc., Roche Diagnostics International Ltd., Koninklijke Philips N.V, Hamamatsu Photonics K.K, Sectra AB Proscia Inc., Indica Labs Inc., 3DHISTECH Ltd., Visiopharm A/S, Ibex Medical Analytics Ltd., Aiforia Technologies Plc, Grundium Oy, Huron Technologies International Inc., PreciPoint GmbH, Mikroscan Technologies Inc., OptraSCAN Inc., Corista LLC, Inspirata Inc., Paige AI Inc., Glencoe Software Inc. and more.
Current emerging trends and opportunities are extensively analysed in the digital pathology market report.
The forecast of the digital pathology market comes along with additional information associated with opportunities, restrains and key drivers in the market.
The report Digital Pathology Market – is segmented by product, application, end user and geography.
Get a free sample on the Digital Pathology Market report
Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.
We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.
For more insights, please visit, https://www.nextmsc.com
Tushmi Dutta is a focused researcher specializing in detailed analysis and insight-driven research across diverse business landscapes. She supports strategic initiatives through structured data interpretation, thorough validation, and clear communication of findings that aid informed decision-making. With a strong interest in writing, she enjoys presenting research insights in an engaging and accessible manner. Beyond work, she enjoys traveling, reading, painting, and continuously learning new skills that contribute to her creative and professional growth.
Supradip Baul is an accomplished business consultant and strategist with over a decade of rich experience in market intelligence, strategy, technology, and business transformation. His work has included rigorous qualitative and quantitative analysis across multiple industries, helping clients shape investment decisions and long-term roadmaps. Earlier in his career, he was associated with Gartner, where he contributed to industry-leading reports and market share analyses. He has worked with leading global companies and holds an MBA with a dual specialization in Marketing and Finance.
This website uses cookies to ensure you get the best experience on our website. Learn more
✖
Add Comment